On March 13, 2018 Pearl Diagnostics was awarded US patent# 9,915,657 for a lateral flow device (LFD) for the detection of Aspergillus antigens in urine.
Aspergillosis is a common infection in people with weakened immune systems, especially after transplantation or cancer therapy. This simple assay will allow for early detection to prevent severe disease.